Cart
sales@molnova.com
Elarofiban
CAS No. 198958-88-2
Elarofiban( —— )
Catalog No. M34233 CAS No. 198958-88-2
Elarofiban(RWJ-53308) is a novel and orally active GPIIb/IIIa antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 922 | In Stock |
|
| 10MG | 1226 | In Stock |
|
| 25MG | 1853 | In Stock |
|
| 50MG | 2437 | In Stock |
|
| 100MG | 3283 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameElarofiban
-
NoteResearch use only, not for human use.
-
Brief DescriptionElarofiban(RWJ-53308) is a novel and orally active GPIIb/IIIa antagonist.
-
DescriptionElarofiban (RWJ-53308) is a nonpeptide, orally active fibrinogen receptor antagonist. Elarofiban has the potential for platelet mediated thrombotic disorders research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIntegrin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number198958-88-2
-
Formula Weight416.51
-
Molecular FormulaC22H32N4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H](NC(=O)[C@H]1CN(C(CCC2CCNCC2)=O)CCC1)(CC(O)=O)C=3C=CC=NC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Judith H. Cohen, et al. A Practical Synthesis of the Platelet Fibrinogen Antagonist, Elarofiban. Organic Process Research & Development 2003, 7, 866-872.
molnova catalog
related products
-
RUC-4
A potent, selective, non-RGD-mimetic αIIbβ3 integrin receptor antagonist with IC50 of 45 nM, with no activity on αVβ3 receptors.
-
Cyclo(RADfK)
Cyclo(RADfK) is a selective α(v)β(3) integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis.Cyclo(RADfK) is a negative control for the cyclo (-RGDfK-), the RGD peptide.
-
OSU-T315
A novel potent, orally active ILK (integrin-linked kinase) inhibitor with IC50 of 0.6 uM.
